Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* trial)

American Journal of Cardiology

Volumn 92, Issue 2, 2003, Pages 152-160

  Jones, Peter H ^a   Davidson, Michael H ^b   Stein, Evan A ^b   Bays, Harold E ^b   McKenney, James M ^b   Miller, Elinor ^b   Cain, Valerie A ^b   Blasetto, James W ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; TRIACYLGLYCEROL;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYALGIA; PAIN; PHARYNGITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT OUTCOME;

EID: 0038645309     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(03)00530-7     Document Type: Article

References (18)

1. Davidson M., Ma P., Stein E.A., Gotto A.M. Jr, Raza A., Chitra R., Hutchinson H. Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia. Am J Cardiol. 89:2002;268-275.
2. Olsson A.G., Istad H., Luurila O., Ose L., Stender S., Tuomilehto J., Wiklund O., Southworth H., Pears J., Wilpshaar J.W. Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemia. Am Heart J. 144:2002;1044-1051.
3. Brown W.V., Bays H.E., Hassman D.R., McKenney J., Chitra R., Hutchinson H., Miller E. Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesterolemia a randomized, double-blind, 52-week trial . Am Heart J. 144:2002;1036-1043.
4. Paoletti R., Fahmy M., Mahla G., Mizan J., Southworth H. Rosuvastatin demonstrates greater reduction of low-density lipoprotein cholesterol compared with pravastatin and simvastatin in hypercholesterolaemic patients a randomized, double-blind study . J Cardiovasc Risk. 8:2001;383-390.
5. Jones P., Kafonek S., Laurora I., Hunninghake D. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study). Am J Cardiol. 81:1998;582-587.
6. Schneck D.W., Knopp R.H., Ballantyne C.M., McPherson R., Chitra R.R., Simonson S.G. Comparative effects of rosuvastatin and atorvastatin across their dose ranges in patients with hypercholesterolemia and without active arterial disease. Am J Cardiol. 91:2003;33-41.
7. NCEP Expert Panel. Third Report of National Cholesterol Education Program (NCER) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final Report. Circulation 2002;106:3143-3421.
8. Wood D., De Backer G., Faergeman O., Graham I., Mancia G., Pyorola K. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and Other Societies on Coronary Prevention. Eur Heart J. 19:1998;1434-1503.
9. Remmell P.S., Gorder D.D., Hall Y., Tillotson J.L. Assessing dietary adherence in the Multiple Risk Factor Intervention Trial (MRFIT). I. Use of a dietary monitoring tool. J Am Diet Assoc. 76:1980;351-356.
10. Myers G.L., Cooper G.R., Winn C.L., Smith S.J. The Centers for Disease Control-National Heart, Lung, and Blood Institute Lipid Standardization Program an approach to accurate and precise lipid measurements . Clin Lab Med. 9:1989;105-135.
11. Warnick G., Albers J. A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high-density lipoprotein cholesterol. J Lipid Res. 19:1978;65-76.
12. Friedewald W.T., Levy R.I., Frederickson D.S. Estimation of concentration of low density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge. Clin Chem. 18:1972;499-502.
13. Lipid Research Clinics Program. Manual of Operations: Lipid and Lipoprotein Analysis. Washington, DC: US Department of Health, Education, and Welfare. Publication no. NIH 75-628, 1982.
14. Knopp R.H. Drug treatment of lipid disorders. N Engl J Med. 341:1999;498-511.
15. Miller R.G. Jr. Simultaneous Statistical Inference. 2nd Ed:1981;Springer-Verlag, New York, NY.
16. Illingworth D.R., Crouse J.R. III, Hunninghake D.B., Davidson M.H., Escobar I.D., Stalenhoef A.F., Paragh G., Ma P.T., Liu M., et al. A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial. Curr Med Res Opin. 17:2001;43-50.
17. Olsson A.G., Pears J., McKellar J., Mizan J., Raza A. Effect of rosuvastatin on low-density lipoprotein cholesterol in patients with hypercholesterolemia. Am J Cardiol. 88:2001;504-508.
18. Hunninghake D., Bakker-Arkema R.G., Wigand J.P., Drehobl M., Schrott H., Early J.L., Abdallah P., McBride S., Black D.M. Treating to meet NCEP-recommended LDL cholesterol concentrations with atorvastatin, fluvastatin, lovastatin, or simvastatin in patients with risk factors for coronary heart disease. J Fam Pract. 47:1998;349-356.